On 08 May 2014
Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 08 May 2014 to consider and approve the Company's audited financial statements for the year ended 31 March 2014 and to consider and recommend dividend, if any, on equity shares for the year ended 31 March 2014.Powered by Capital Market - Live News
